[spacer image]
BD
BD - Worldwide
Select Another Location
[spacer image] [spacer image] Physicians [spacer image] Labs [spacer image]
[spacer image] [spacer image]
TriPath
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]

Did you know?
[spacer image] BD revolutionized the field of cellular analysis with the BD FACS™ fluorescence-activated cell sorter, introduced in 1973. Learn more about BD's history » [spacer image]
[spacer image]

BD Diagnostics - TriPath offers products for cervical cytology screening. Our BD SurePath™ Pap test, BD PrepStain™ Slide Processor, BD FocalPoint™ Slide Profiler and BD FocalPoint™ GS Imaging System, together, provide an integrated solution for sample preparation, processing, staining, and computerized analysis of liquid-based Pap testing.

In addition to the cervical cytology products, BD markets BD ProEx™ C Reagents for the detection of aberrant S-phase induction and BD CytoRich™ Preservative for non-gynecological applications.
[spacer image] [spacer image] [spacer image]

[spacer image] BD SurePath™ is now FDA approved for out-of-vial CT/GC testing »
[spacer image]

[spacer image]

<br>Introducing the BD FocalPoint™ GS Imaging System for Intelligent Pap Imaging™<br>
<br>Introducing the BD FocalPoint™ GS Imaging System for Intelligent Pap Imaging™<br>
[spacer image]
Introducing the BD FocalPoint™ GS Imaging System for Intelligent Pap Imaging™

BD FocalPoint™ GS Imaging System »
[spacer image]

[spacer image]

[spacer image] BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management (May 2009) »
[spacer image]
[spacer image]

[spacer image] Learn More About...

[bullet] BD Expands Diagnostic Testing Offerings in Women’s Health »

[bullet] BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer »

[bullet] Millions of patients and their doctors rely on the BD SurePath™ liquid-based Pap test every month to ensure their cervical health. »

[bullet] BD Receives FDA Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer »

[bullet] Cervical Cytology products »

[bullet] Molecular Oncology products »

[bullet] Non-Gynecological applications »

[bullet] Cervical cancer screening information for patients »

[spacer image]
[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]